Leptomeningeal Metastases: How Best to Assess Response

Overview

Journal Neuro Oncol

Publisher Oxford University Press

Specialties Neurology
Oncology

Date 2020 Aug 10

PMID 32770188

Citations 1

Authors

Marc C Chamberlain

Affiliations

Soon will be listed here.

Citing Articles

Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.

Familiar A, Kazerooni A, Vossough A, Ware J, Bagheri S, Khalili N Neuro Oncol. 2024; 26(9):1557-1571.

PMID: 38769022 PMC: 11376457. DOI: 10.1093/neuonc/noae093.

References

Peng J, Zhou H, Tang O, Chang K, Wang P, Zeng X . Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data. Neuro Oncol. 2020; 22(10):1536-1544. PMC: 7566367. DOI: 10.1093/neuonc/noaa072. View

Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J . Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol. 2017; 19(4):484-492. PMC: 5464328. DOI: 10.1093/neuonc/now183. View

Le Rhun E, Devos P, Boulanger T, Smits M, Brandsma D, Ruda R . The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal. Neuro Oncol. 2019; 21(5):648-658. PMC: 6502503. DOI: 10.1093/neuonc/noz024. View

Warren K, Vezina G, Poussaint T, Warmuth-Metz M, Chamberlain M, Packer R . Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol. 2017; 20(1):13-23. PMC: 5761545. DOI: 10.1093/neuonc/nox087. View

Nayak L, DeAngelis L, Brandes A, Peereboom D, Galanis E, Lin N . The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro Oncol. 2017; 19(5):625-635. PMC: 5464449. DOI: 10.1093/neuonc/nox029. View